{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:13:04Z","timestamp":1789665184234,"version":"4.0.1"},"reference-count":100,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"am","delay-in-days":348,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010846","name":"Health and Family Planning Commission of Hubei Province","doi-asserted-by":"publisher","award":["WJ2021M255"],"award-info":[{"award-number":["WJ2021M255"]}],"id":[{"id":"10.13039\/501100010846","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2042023kf0054"],"award-info":[{"award-number":["2042023kf0054"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017691","name":"Guangxi Key Research and Development Program","doi-asserted-by":"publisher","award":["2021BCA114"],"award-info":[{"award-number":["2021BCA114"]}],"id":[{"id":"10.13039\/501100017691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Molecular Medicine"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.molmed.2023.07.001","type":"journal-article","created":{"date-parts":[[2023,7,22]],"date-time":"2023-07-22T16:09:18Z","timestamp":1690042158000},"page":"859-872","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Alternative splicing: a bridge connecting NAFLD and HCC"],"prefix":"10.1016","volume":"29","author":[{"given":"Kequan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiangen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molmed.2023.07.001_bb0005","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000014595","article-title":"Zygomatic bone metastasis from hepatocellular carcinoma and the therapeutic efficacy of apatinib: a case report and literature review","volume":"98","author":"Lei","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.molmed.2023.07.001_bb0010","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/j.gastro.2018.08.065","article-title":"Epidemiology and management of hepatocellular carcinoma","volume":"156","author":"Kulik","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molmed.2023.07.001_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.acr.2020.10.001","article-title":"Hepatocellular carcinoma (HCC): epidemiology, etiology and molecular classification","volume":"149","author":"Chidambaranathan-Reghupaty","year":"2021","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.molmed.2023.07.001_bb0020","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1111\/liv.12818","article-title":"Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study","volume":"35","author":"Park","year":"2015","journal-title":"Liver Int."},{"key":"10.1016\/j.molmed.2023.07.001_bb0025","article-title":"Metabolic risks are increasing in non-B non-C early-stage hepatocellular carcinoma: a 10-year follow-up study","volume":"12","author":"Lin","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.molmed.2023.07.001_bb0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1574888X16666211207103628","article-title":"Role of RNA splicing in regulation of cancer stem cell","volume":"18","author":"Tripathi","year":"2023","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"10.1016\/j.molmed.2023.07.001_bb0035","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba4448","article-title":"Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis","volume":"12","author":"Govaere","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.molmed.2023.07.001_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2021.100534","article-title":"Alternative splicing and liver disease","volume":"26","author":"Baralle","year":"2021","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.molmed.2023.07.001_bb0045","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1210\/jc.2019-00021","article-title":"Dysregulation of the splicing machinery is associated to the development of nonalcoholic fatty liver disease","volume":"104","author":"Del Rio-Moreno","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.molmed.2023.07.001_bb0050","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s12032-022-01726-8","article-title":"RNA splicing: a dual-edged sword for hepatocellular carcinoma","volume":"39","author":"Kashyap","year":"2022","journal-title":"Med. Oncol."},{"key":"10.1016\/j.molmed.2023.07.001_bb0055","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev-biochem-060614-034242","article-title":"Regulation of alternative splicing through coupling with transcription and chromatin structure","volume":"84","author":"Naftelberg","year":"2015","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.molmed.2023.07.001_bb0060","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1042\/BCJ20200475","article-title":"Linking transcription, RNA polymerase II elongation and alternative splicing","volume":"477","author":"Giono","year":"2020","journal-title":"Biochem. J."},{"key":"10.1016\/j.molmed.2023.07.001_bb0065","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3390\/biom11020143","article-title":"The role of H3K4 trimethylation in CpG islands hypermethylation in cancer","volume":"11","author":"Zardo","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.molmed.2023.07.001_bb0070","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1186\/s12885-015-1983-5","article-title":"Epigenetic regulation of CDH1 exon 8 alternative splicing in gastric cancer","volume":"15","author":"Li","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.molmed.2023.07.001_bb0075","doi-asserted-by":"crossref","first-page":"R70","DOI":"10.1186\/gb-2010-11-7-r70","article-title":"Contrasting chromatin organization of CpG islands and exons in the human genome","volume":"11","author":"Choi","year":"2010","journal-title":"Genome Biol."},{"key":"10.1016\/j.molmed.2023.07.001_bb0080","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.tig.2015.03.002","article-title":"The alternative role of DNA methylation in splicing regulation","volume":"31","author":"Lev Maor","year":"2015","journal-title":"Trends Genet."},{"key":"10.1016\/j.molmed.2023.07.001_bb0085","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nature14234","article-title":"N6-methyladenosine-dependent RNA structural switches regulate RNA\u2013protein interactions","volume":"518","author":"Liu","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.molmed.2023.07.001_bb0090","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.molcel.2016.01.012","article-title":"Nuclear m6A reader YTHDC1 regulates mRNA splicing","volume":"61","author":"Xiao","year":"2016","journal-title":"Mol. Cell"},{"key":"10.1016\/j.molmed.2023.07.001_bb0095","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/cr.2014.151","article-title":"FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis","volume":"24","author":"Zhao","year":"2014","journal-title":"Cell Res."},{"key":"10.1016\/j.molmed.2023.07.001_bb0100","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/s41419-021-04013-y","article-title":"PPM1G promotes the progression of hepatocellular carcinoma via phosphorylation regulation of alternative splicing protein SRSF3","volume":"12","author":"Chen","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.molmed.2023.07.001_bb0105","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/j.cmet.2021.09.008","article-title":"DRAK2 aggravates nonalcoholic fatty liver disease progression through SRSF6-associated RNA alternative splicing","volume":"33","author":"Li","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.molmed.2023.07.001_bb0110","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s12104-022-10117-z","article-title":"1H, 13C, and 15N assignments of the mRNA binding protein hnRNP A18","volume":"17","author":"Coburn","year":"2022","journal-title":"Biomol. NMR Assign."},{"key":"10.1016\/j.molmed.2023.07.001_bb0115","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1158\/1541-7786.MCR-21-0581","article-title":"Protein phosphatase 2A-dependent mitotic hnRNPA1 dephosphorylation and TERRA formation facilitate telomere capping","volume":"20","author":"Sui","year":"2022","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.molmed.2023.07.001_bb0120","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41420-021-00498-w","article-title":"SRSF1 promotes the inclusion of exon 3 of SRA1 and the invasion of hepatocellular carcinoma cells by interacting with exon 3 of SRA1pre-mRNA","volume":"7","author":"Lei","year":"2021","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.molmed.2023.07.001_bb0125","first-page":"S130","article-title":"Effects of high fat medium conditions on cellular gene expression profile: a network analysis approach","volume":"12","author":"Asadzadeh-Aghdaei","year":"2019","journal-title":"Gastroenterol. Hepatol. Bed Bench"},{"key":"10.1016\/j.molmed.2023.07.001_bb0130","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41467-023-35932-3","article-title":"Splicing factor SRSF1 deficiency in the liver triggers NASH-like pathology and cell death","volume":"14","author":"Arif","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2023.07.001_bb0135","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1158\/1541-7786.MCR-12-0213","article-title":"Hepatocyte growth factor enhances alternative splicing of the Kruppel-like factor 6 (KLF6) tumor suppressor to promote growth through SRSF1","volume":"10","author":"Munoz","year":"2012","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.molmed.2023.07.001_bb0140","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1053\/j.gastro.2008.02.015","article-title":"Ras promotes growth by alternative splicing-mediated inactivation of the KLF6 tumor suppressor in hepatocellular carcinoma","volume":"134","author":"Yea","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.molmed.2023.07.001_bb0145","article-title":"A novel circRNA hsa_circRNA_002178 as a diagnostic marker in hepatocellular carcinoma enhances cell proliferation, invasion, and tumor growth by stabilizing SRSF1 expression","volume":"2022","author":"Li","year":"2022","journal-title":"J. Oncol."},{"key":"10.1016\/j.molmed.2023.07.001_bb0150","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.bbrc.2020.10.061","article-title":"Long noncoding RNA LINC02580 suppresses the invasion-metastasis cascade in hepatocellular carcinoma by targeting SRSF1","volume":"533","author":"Xu","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molmed.2023.07.001_bb0155","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41389-023-00447-5","article-title":"HLTF promotes hepatocellular carcinoma progression by enhancing SRSF1 stability and activating ERK\/MAPK pathway","volume":"12","author":"Xu","year":"2023","journal-title":"Oncogenesis"},{"key":"10.1016\/j.molmed.2023.07.001_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.153994","article-title":"2,3,5,4\u2032-Tetrahydroxy-stilbene-2-O-beta-D-glucoside ameliorates NAFLD via attenuating hepatic steatosis through inhibiting mitochondrial dysfunction dependent on SIRT5","volume":"99","author":"Zhang","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.molmed.2023.07.001_bb0165","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1158\/0008-5472.CAN-16-1919","article-title":"SRSF2 regulates alternative splicing to drive hepatocellular carcinoma development","volume":"77","author":"Luo","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2023.07.001_bb0170","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.3390\/ijms24043263","article-title":"HBV enhances sorafenib resistance in hepatocellular carcinoma by reducing ferroptosis via SRSF2-mediated abnormal PCLAF splicing","volume":"24","author":"Liu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molmed.2023.07.001_bb0175","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1074\/jbc.M111.291229","article-title":"DNA methylation-regulated miR-193a-3p dictates resistance of hepatocellular carcinoma to 5-fluorouracil via repression of SRSF2 expression","volume":"287","author":"Ma","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molmed.2023.07.001_bb0180","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1172\/JCI127374","article-title":"Degradation of splicing factor SRSF3 contributes to progressive liver disease","volume":"129","author":"Kumar","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2023.07.001_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2023.100342","article-title":"Loss of splicing factor SRSF3 impairs lipophagy through ubiquitination and degradation of syntaxin 17 in hepatocytes","volume":"64","author":"Li","year":"2023","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.molmed.2023.07.001_bb0190","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/ncomms2342","article-title":"Splicing factor SRSF3 is crucial for hepatocyte differentiation and metabolic function","volume":"4","author":"Sen","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2023.07.001_bb0195","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/hep.27380","article-title":"Deletion of serine\/arginine-rich splicing factor 3 in hepatocytes predisposes to hepatocellular carcinoma in mice","volume":"61","author":"Sen","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2023.07.001_bb0200","article-title":"Hepatocyte deletion of IGF2 prevents DNA damage and tumor formation in hepatocellular carcinoma","volume":"9","author":"Kumar","year":"2022","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.molmed.2023.07.001_bb0205","doi-asserted-by":"crossref","first-page":"14832","DOI":"10.3390\/ijms232314832","article-title":"SRSF3 and HNRNPH1 regulate radiation-induced alternative splicing of protein arginine methyltransferase 5 in hepatocellular carcinoma","volume":"23","author":"Wen","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molmed.2023.07.001_bb0210","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13046-023-02626-z","article-title":"Retraction Note: LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2","volume":"42","author":"Jia","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.molmed.2023.07.001_bb0215","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/hep.30147","article-title":"A coiled-coil domain containing 50 splice variant is modulated by serine\/arginine-rich splicing factor 3 and promotes hepatocellular carcinoma in mice by the Ras signaling pathway","volume":"69","author":"Wang","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2023.07.001_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215711","article-title":"RNA binding protein RALY activates the cholesterol synthesis pathway through an MTA1 splicing switch in hepatocellular carcinoma","volume":"538","author":"Qiao","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.molmed.2023.07.001_bb0225","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s12072-019-09950-7","article-title":"Alteration of splicing factors' expression during liver disease progression: impact on hepatocellular carcinoma outcome","volume":"13","author":"Wang","year":"2019","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.molmed.2023.07.001_bb0230","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1261\/rna.042259.113","article-title":"Splicing factor hnRNP A2 activates the Ras\u2013MAPK\u2013ERK pathway by controlling A-Raf splicing in hepatocellular carcinoma development","volume":"20","author":"Shilo","year":"2014","journal-title":"RNA"},{"key":"10.1016\/j.molmed.2023.07.001_bb0235","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1093\/nar\/gkac165","article-title":"Dysregulated RNA polyadenylation contributes to metabolic impairment in non-alcoholic fatty liver disease","volume":"50","author":"Jobbins","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2023.07.001_bb0240","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.cmet.2011.06.007","article-title":"Expression of the splicing factor gene SFRS10 is reduced in human obesity and contributes to enhanced lipogenesis","volume":"14","author":"Pihlajamaki","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.molmed.2023.07.001_bb0245","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/s41467-022-29016-x","article-title":"The aberrant upregulation of exon 10-inclusive SREK1 through SRSF10 acts as an oncogenic driver in human hepatocellular carcinoma","volume":"13","author":"Chang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2023.07.001_bb0250","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s13046-022-02558-0","article-title":"SRSF10 stabilizes CDC25A by triggering exon 6 skipping to promote hepatocarcinogenesis","volume":"41","author":"Liu","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.molmed.2023.07.001_bb0255","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/jmcb\/mjz050","article-title":"Loss of hnRNP A1 in murine skeletal muscle exacerbates high-fat diet-induced onset of insulin resistance and hepatic steatosis","volume":"12","author":"Zhao","year":"2020","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.molmed.2023.07.001_bb0260","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/s41419-021-04167-9","article-title":"CHD1L prevents lipopolysaccharide-induced hepatocellular carcinomar cell death by activating hnRNP A2\/B1-nmMYLK axis","volume":"12","author":"Wang","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.molmed.2023.07.001_bb0265","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/hep.29654","article-title":"Long noncoding RNA H19 interacts with polypyrimidine tract-binding protein 1 to reprogram hepatic lipid homeostasis","volume":"67","author":"Liu","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2023.07.001_bb0270","doi-asserted-by":"crossref","first-page":"5719","DOI":"10.7150\/thno.42010","article-title":"Skipping of exon 10 in Axl pre-mRNA regulated by PTBP1 mediates invasion and metastasis process of liver cancer cells","volume":"10","author":"Shen","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.molmed.2023.07.001_bb0275","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/s41467-020-14437-3","article-title":"MTR4 drives liver tumorigenesis by promoting cancer metabolic switch through alternative splicing","volume":"11","author":"Yu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2023.07.001_bb0280","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/hep.30921","article-title":"hnRNPU\/TrkB defines a chromatin accessibility checkpoint for liver injury and nonalcoholic steatohepatitis pathogenesis","volume":"71","author":"Xiong","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2023.07.001_bb0285","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1158\/0008-5472.CAN-19-0376","article-title":"DIS3L2 promotes progression of hepatocellular carcinoma via hnRNP U-mediated alternative splicing","volume":"79","author":"Xing","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2023.07.001_bb0290","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0955-0674(00)00097-1","article-title":"Mechanisms of fidelity in pre-mRNA splicing","volume":"12","author":"Reed","year":"2000","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.molmed.2023.07.001_bb0295","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1126\/science.1193494","article-title":"The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes","volume":"330","author":"Levine","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.molmed.2023.07.001_bb0300","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1172\/JCI74382","article-title":"Splicing regulator SLU7 is essential for maintaining liver homeostasis","volume":"124","author":"Elizalde","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.molmed.2023.07.001_bb0305","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1093\/nar\/gkz014","article-title":"Splicing events in the control of genome integrity: role of SLU7 and truncated SRSF3 proteins","volume":"47","author":"Jimenez","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.molmed.2023.07.001_bb0310","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.toxlet.2020.04.012","article-title":"Effect of PFOA on DNA methylation and alternative splicing in mouse liver","volume":"329","author":"Wen","year":"2020","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.molmed.2023.07.001_bb0315","first-page":"180","article-title":"High expression of serine and arginine-rich splicing factor 9 (SRSF9) is associated with hepatocellular carcinoma progression and a poor prognosis","volume":"15","author":"Zhang","year":"2022","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.molmed.2023.07.001_bb0320","article-title":"CpG site-specific methylation-modulated divergent expression of PRSS3 transcript variants facilitates nongenetic intratumor heterogeneity in human hepatocellular carcinoma","volume":"12","author":"Lin","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.molmed.2023.07.001_bb0325","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.2217\/epi-2019-0009","article-title":"Comprehensive analysis of differences of N6-methyladenosine RNA methylomes between high-fat-fed and normal mouse livers","volume":"11","author":"Luo","year":"2019","journal-title":"Epigenomics"},{"key":"10.1016\/j.molmed.2023.07.001_bb0330","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.gendis.2021.01.005","article-title":"Critical roles of FTO-mediated mRNA m6A demethylation in regulating adipogenesis and lipid metabolism: implications in lipid metabolic disorders","volume":"9","author":"Yang","year":"2022","journal-title":"Genes Dis."},{"key":"10.1016\/j.molmed.2023.07.001_bb0335","first-page":"538","article-title":"(2018) FTO promotes SREBP1c maturation and enhances CIDEC transcription during lipid accumulation in HepG2 cells","volume":"5","author":"Chen","year":"1863","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.molmed.2023.07.001_bb0340","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.352","article-title":"AMD1 upregulates hepatocellular carcinoma cells stemness by FTO mediated mRNA demethylation","volume":"11","author":"Bian","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.molmed.2023.07.001_bb0345","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1002\/hep.31222","article-title":"SIRT1 regulates N6-methyladenosine RNA modification in hepatocarcinogenesis by inducing RANBP2-dependent FTO SUMOylation","volume":"72","author":"Liu","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2023.07.001_bb0350","first-page":"6084","article-title":"m6A demethylase FTO promotes hepatocellular carcinoma tumorigenesis via mediating PKM2 demethylation","volume":"11","author":"Li","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.molmed.2023.07.001_bb0355","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1038\/s41467-020-19787-6","article-title":"Direct RNA sequencing reveals m6A modifications on adenovirus RNA are necessary for efficient splicing","volume":"11","author":"Price","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.molmed.2023.07.001_bb0360","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bbrc.2019.08.018","article-title":"METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism","volume":"518","author":"Xie","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molmed.2023.07.001_bb0365","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/hep.28885","article-title":"METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N6-methyladenosine-dependent primary MicroRNA processing","volume":"65","author":"Ma","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.molmed.2023.07.001_bb0370","article-title":"KIAA1429 regulates alternative splicing events of cancer-related genes in hepatocellular carcinoma","volume":"12","author":"Liu","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.molmed.2023.07.001_bb0375","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3390\/cancers14030560","article-title":"Alternative splicing, epigenetic modifications and cancer: a dangerous triangle, or a hopeful one?","volume":"14","author":"Gimeno-Valiente","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.molmed.2023.07.001_bb0380","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3389\/fonc.2020.01105","article-title":"Mechanisms of RNA N6-methyladenosine in hepatocellular carcinoma: from the perspectives of etiology","volume":"10","author":"Lu","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.molmed.2023.07.001_bb0385","doi-asserted-by":"crossref","first-page":"6052","DOI":"10.1167\/iovs.13-12422","article-title":"Topical antiangiogenic SRPK1 inhibitors reduce choroidal neovascularization in rodent models of exudative AMD","volume":"54","author":"Gammons","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.molmed.2023.07.001_bb0390","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.chembiol.2018.01.013","article-title":"SRPKIN-1: a covalent SRPK1\/2 inhibitor that potently converts VEGF from pro-angiogenic to anti-angiogenic isoform","volume":"25","author":"Hatcher","year":"2018","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.molmed.2023.07.001_bb0395","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1021\/acschembio.6b01048","article-title":"Development of potent, selective SRPK1 inhibitors as potential topical therapeutics for neovascular eye disease","volume":"12","author":"Batson","year":"2017","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.molmed.2023.07.001_bb0400","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12867-015-0044-6","article-title":"Deciphering targeting rules of splicing modulator compounds: case of TG003","volume":"16","author":"Sakuma","year":"2015","journal-title":"BMC Mol. Biol."},{"key":"10.1016\/j.molmed.2023.07.001_bb0405","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s10120-020-01062-8","article-title":"Phosphoproteomic analysis identifies CLK1 as a novel therapeutic target in gastric cancer","volume":"23","author":"Babu","year":"2020","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.molmed.2023.07.001_bb0410","doi-asserted-by":"crossref","first-page":"7963","DOI":"10.1038\/s41598-021-86908-6","article-title":"CDC2-like (CLK) protein kinase inhibition as a novel targeted therapeutic strategy in prostate cancer","volume":"11","author":"Uzor","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.molmed.2023.07.001_bb0415","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13100-015-0041-9","article-title":"Repbase update, a database of repetitive elements in eukaryotic genomes","volume":"6","author":"Bao","year":"2015","journal-title":"Mob. DNA"},{"key":"10.1016\/j.molmed.2023.07.001_bb0420","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41571-020-0350-x","article-title":"Roles and mechanisms of alternative splicing in cancer \u2013 implications for care","volume":"17","author":"Bonnal","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.molmed.2023.07.001_bb0425","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1774095","article-title":"Metformin suppresses hepatocellular carcinoma through regulating alternative splicing of LGR4","volume":"2022","author":"Zhuo","year":"2022","journal-title":"J. Oncol."},{"key":"10.1016\/j.molmed.2023.07.001_bb0430","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1007006","article-title":"Melatonin inhibits HCC progression through regulating the alternative splicing of NEMO","volume":"13","author":"Bai","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.molmed.2023.07.001_bb0435","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1101\/gad.2009411","article-title":"The anti-tumor drug E7107 reveals an essential role for SF3b in remodeling U2 snRNP to expose the branch point-binding region","volume":"25","author":"Folco","year":"2011","journal-title":"Genes Dev."},{"key":"10.1016\/j.molmed.2023.07.001_bb0440","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrneurol.2017.148","article-title":"Antisense oligonucleotides: the next frontier for treatment of neurological disorders","volume":"14","author":"Rinaldi","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.molmed.2023.07.001_bb0445","article-title":"Modulation of Bcl-x alternative splicing induces apoptosis of human hepatic stellate cells","volume":"2016","author":"Wu","year":"2016","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.molmed.2023.07.001_bb0450","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1440-1746.2009.05785.x","article-title":"Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression","volume":"24","author":"Farrell","year":"2009","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.molmed.2023.07.001_bb0455","article-title":"Liver-specific insulin receptor isoform A expression enhances hepatic glucose uptake and ameliorates liver steatosis in a mouse model of diet-induced obesity","volume":"12","author":"Lopez-Pastor","year":"2019","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.molmed.2023.07.001_bb0460","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1128\/MCB.01709-08","article-title":"SRp20 and CUG-BP1 modulate insulin receptor exon 11 alternative splicing","volume":"29","author":"Sen","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.molmed.2023.07.001_bb0465","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1158\/0008-5472.CAN-12-3824","article-title":"Mitogenic insulin receptor-A is overexpressed in human hepatocellular carcinoma due to EGFR-mediated dysregulation of RNA splicing factors","volume":"73","author":"Chettouh","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.molmed.2023.07.001_bb0470","doi-asserted-by":"crossref","first-page":"8558","DOI":"10.7150\/thno.44873","article-title":"E3 ligase ZFP91 inhibits hepatocellular carcinoma metabolism reprogramming by regulating PKM splicing","volume":"10","author":"Chen","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.molmed.2023.07.001_bb0475","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.tig.2018.10.002","article-title":"RNA splicing and disease: animal models to therapies","volume":"35","author":"Montes","year":"2019","journal-title":"Trends Genet."},{"key":"10.1016\/j.molmed.2023.07.001_bb0480","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.7150\/ijbs.46751","article-title":"Serine\/arginine-rich splicing factors: the bridge linking alternative splicing and cancer","volume":"16","author":"Zheng","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.molmed.2023.07.001_bb0485","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1612","article-title":"The roles of hnRNP A2\/B1 in RNA biology and disease","volume":"12","author":"Liu","year":"2021","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"10.1016\/j.molmed.2023.07.001_bb0490","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.3390\/ijms24065086","article-title":"Role of heterogeneous nuclear ribonucleoproteins in the cancer-immune landscape","volume":"24","author":"Sudhakaran","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.molmed.2023.07.001_bb0495","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00439-016-1683-5","article-title":"The hnRNP family: insights into their role in health and disease","volume":"135","author":"Geuens","year":"2016","journal-title":"Hum. Genet."},{"key":"10.1016\/j.molmed.2023.07.001_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101540","article-title":"A novel lncRNA RP11-386G11.10 reprograms lipid metabolism to promote hepatocellular carcinoma progression","volume":"63","author":"Xu","year":"2022","journal-title":"Mol. Metab."}],"container-title":["Trends in Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147149142300151X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147149142300151X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T07:29:15Z","timestamp":1761463755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147149142300151X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":100,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S147149142300151X"],"URL":"https:\/\/doi.org\/10.1016\/j.molmed.2023.07.001","relation":{},"ISSN":["1471-4914"],"issn-type":[{"value":"1471-4914","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alternative splicing: a bridge connecting NAFLD and HCC","name":"articletitle","label":"Article Title"},{"value":"Trends in Molecular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmed.2023.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}